Furthermore, the significant reduction in the percentage of freshly isolated CD56+ cells in G3 compared with G2 tumors, accompanied by our previous observations on tumor-infiltrating CD56+ cells in IHC analysis, may represent a feature of CC progression. This evidence concerns the gene NCAM1 and neoplasm.